These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N. Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225 [Abstract] [Full Text] [Related]
6. [Vaccination against the paralytic form of EHV1?]. Breukink HJ, Binkhorst GJ, van Oirschot JT. Tijdschr Diergeneeskd; 1983 May 01; 108(9):359. PubMed ID: 6306862 [No Abstract] [Full Text] [Related]
7. [EHV1, to vaccinate or not?]. Binkhorst GJ, van Oirschot JT, Breukink HJ. Tijdschr Diergeneeskd; 1985 Mar 01; 110(5):189-90. PubMed ID: 2984805 [No Abstract] [Full Text] [Related]
19. Cellular and antibody responses to equine herpesviruses 1 and 4. Studdert MJ. J Am Vet Med Assoc; 1995 Sep 15; 207(6):698-701. PubMed ID: 7657564 [No Abstract] [Full Text] [Related]